Journal
DERMATOLOGY AND THERAPY
Volume 2, Issue 1, Pages -Publisher
ADIS INT LTD
DOI: 10.1007/s13555-012-0008-4
Keywords
Actinic keratosis; Field-directed therapy; Ingenol mebutate
Categories
Ask authors/readers for more resources
Actinic keratoses (AK) are the most common premalignant pathology seen in dermatological practice and represent a burgeoning burden upon health services. Increasingly recognized is the damage to surrounding, perilesional skin, forming the premise for field-directed therapy. Ingenol mebutate gel is a novel agent for fielddirected treatment of AK, requiring only 2 or 3 days of application. Following an overview of existing treatment modalities, the authors review recent trials and safety data pertaining to the use of ingenol mebutate gel and discuss its role in the treatment of AK.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available